Filing Details
- Accession Number:
- 0000899243-21-026557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 16:16:32
- Reporting Period:
- 2021-06-28
- Accepted Time:
- 2021-06-29 16:16:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1680581 | Fulcrum Therapeutics Inc. | FULC | Pharmaceutical Preparations (2834) | 474839948 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859284 | Christopher Morabito | C/O Fulcrum Therapeutics, Inc. 26 Landsdowne Street Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-28 | 1,100 | $9.16 | 1,100 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
